May 18, 2016
(The Korea Times) – The Korean government will lift its seven-year ban on human stem cell research. The National Bioethics Committee conditionally approved CHA Medical Group’s research plan, allowing the company to use up to 600 human eggs by 2020. Under the approval, the company has to abide strictly by related laws and develop a research monitoring system.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.